Back

Calcium-sensing receptor antagonism as a novel therapeutic for pulmonary fibrosis

2020-03-16 respiratory medicine Title + abstract only
View on medRxiv
Show abstract

BackgroundIdiopathic pulmonary fibrosis (IPF) is a disease with very poor prognosis and no curative therapies. The G protein-coupled, calcium/cation-sensing receptor (CaSR) is activated by environmental pollutants and by arginine-derived polyamines, which are thought to play a role in IPF. Whether the CaSR is involved in the pathogenesis of pulmonary fibrosis is unknown. ObjectiveTo investigate the CaSR as a novel drug target for the treatment of pulmonary fibrosis (PF). Methods and resultsCaS...

Predicted journal destinations